(Q81919190)

English

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model

scientific article published on 01 September 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Clement A Meseda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Alonzo D Garcia

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Arunima Kumar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Anne E Mayer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Jody Manischewitz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Lisa R King

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Hana Golding

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Michael Merchlinsky

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Jerry P Weir

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

339

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

164-175

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

The nature of the immune state produced by inactivated vaccinia virus in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Photochemical Inactivation of DNA and RNA Viruses by Psoralen Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Bioterrorism as a public health threat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

The looming threat of bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Development of a novel vaccinia-neutralization assay based on reporter-gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Developing new smallpox vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Respiratory infection of mice with vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Inactivated Smallpox Vaccine: Immunogenicity of Inactivated Intracellular and Extracellular Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.06.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.06.002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15993917%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81919190&oldid=1655127669"